The idea that the bacteria living in your gut might influence your mood has moved from speculative hypothesis to serious clinical science — and a pilot clinical trial published June 17, 2026, in the Journal of the American Geriatrics Society provides the most direct evidence yet that this biological pathway can be targeted therapeutically in older adults living with depression.
The trial, reported by ScienceDaily and MedicalXpress on June 17, found that older adults who added a daily probiotic to their standard antidepressant treatment experienced modest but meaningful reductions in both depressive and anxiety symptoms compared to patients who received a placebo in addition to their standard care. Both groups showed substantial overall improvements during the trial — but the probiotic group showed meaningfully greater benefit.
